Cleveland Clinic
Overview
Non-profit academic medical center integrating care, research, and educatio
Founded
1921
Deals ยท 12mo
4
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Ayble Health | Sep 2026Participated | $16 MSeries A | |
Strolll | Sep 2026Participated | $7 MDebt | |
Floreo | Apr 2026Led | $1 MOther Equity | |
Enspire DBS Therapy | Jan 2026Participated | $10 MSeries B | |
Mediview XR | Oct 2025Led | $24 MSeries A | |
Method AI | Aug 2025Participated | $20 MSeries A | |
1m | Dec 2024Participated | $7 MSeries A | |
XII Medical | Aug 2024Participated | $45 MSeries B | |
Neuro Therapia | Aug 2024Led | $12 MSeries B | |
Mediview XR | May 2023Participated | $15 MOther Equity | |
Centerline Biomedical | Jun 2022Led | $33 MSeries B | |
XII Medical | May 2022Participated | $30 MSeries A | |
Ayble Health | Sep 2026Participated | $16 MSeries A | |
Strolll | Sep 2026Participated | $7 MDebt | |
Floreo | Apr 2026Led | $1 MOther Equity | |
Enspire DBS Therapy | Jan 2026Participated | $10 MSeries B | |
Mediview XR | Oct 2025Led | $24 MSeries A | |
Method AI | Aug 2025Participated | $20 MSeries A | |
1m | Dec 2024Participated | $7 MSeries A | |
XII Medical | Aug 2024Participated | $45 MSeries B | |
Neuro Therapia | Aug 2024Led | $12 MSeries B | |
Mediview XR | May 2023Participated | $15 MOther Equity | |
Centerline Biomedical | Jun 2022Led | $33 MSeries B | |
XII Medical | May 2022Participated | $30 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 1 | 8 |
| Series B | 2 | 4 |
| Series C+ | 0 | 4 |
| Other Equity | 2 | 1 |
| Debt | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jun '10 | 1 |
| Jul '10 | 0 |
| Aug '10 | 1 |
| Sep '10 | 0 |
| Oct '10 | 0 |
| Nov '10 | 0 |
| Dec '10 | 0 |
| Jan '11 | 0 |
| Feb '11 | 1 |
| Mar '11 | 0 |
| Apr '11 | 0 |
| May '11 | 1 |
| Jun '11 | 0 |
| Jul '11 | 0 |
| Aug '11 | 1 |
| Sep '11 | 0 |
| Oct '11 | 0 |
| Nov '11 | 0 |
| Dec '11 | 0 |
| Jan '12 | 0 |
| Feb '12 | 0 |
| Mar '12 | 0 |
| Apr '12 | 0 |
| May '12 | 0 |
| Jun '12 | 0 |
| Jul '12 | 0 |
| Aug '12 | 0 |
| Sep '12 | 0 |
| Oct '12 | 0 |
| Nov '12 | 0 |
| Dec '12 | 0 |
| Jan '13 | 0 |
| Feb '13 | 0 |
| Mar '13 | 0 |
| Apr '13 | 0 |
| May '13 | 0 |
| Jun '13 | 0 |
| Jul '13 | 0 |
| Aug '13 | 0 |
| Sep '13 | 0 |
| Oct '13 | 0 |
| Nov '13 | 0 |
| Dec '13 | 0 |
| Jan '14 | 0 |
| Feb '14 | 0 |
| Mar '14 | 0 |
| Apr '14 | 0 |
| May '14 | 0 |
| Jun '14 | 0 |
| Jul '14 | 0 |
| Aug '14 | 0 |
| Sep '14 | 0 |
| Oct '14 | 0 |
| Nov '14 | 0 |
| Dec '14 | 0 |
| Jan '15 | 0 |
| Feb '15 | 0 |
| Mar '15 | 0 |
| Apr '15 | 0 |
| May '15 | 0 |
| Jun '15 | 1 |
| Jul '15 | 0 |
| Aug '15 | 0 |
| Sep '15 | 0 |
| Oct '15 | 1 |
| Nov '15 | 0 |
| Dec '15 | 0 |
| Jan '16 | 0 |
| Feb '16 | 0 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 0 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 1 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 1 |
| Oct '20 | 1 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 1 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 1 |
| Jun '22 | 1 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 2 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 1 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 2 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 24 |
| Enterprise Software | 6 |
| AR/VR | 4 |
| Data, Analytics & IT | 4 |
| Networks, Cloud & Communication | 2 |
| Space & Frontier Tech | 2 |
| Developer Tools | 1 |
| Consumer & Lifestyle | 1 |
| Hardware & Robotics | 1 |
| Education & Workforce | 1 |
| AI & Machine Learning | 1 |
| Professional Services | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 5 |
| $5M-$10M | 5 |
| $10M-$25M | 10 |
| $25M-$50M | 3 |
| $50M-$100M | 1 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 23 |
| Europe | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| JobsOhio | 5 |
| GE Healthcare | 3 |
| Ajax Health | 2 |
| Alzheimer's Drug Discovery Foundation | 2 |
| Aperture Venture Partners | 2 |
| Atrium Health | 2 |
| Banner Health | 2 |
| Brain Trust Accelerator Fund II | 2 |
| Dolby Family Ventures | 2 |
| Froedtert & the Medical College of Wisconsin | 2 |
| JumpStart Ventures | 2 |
| Mayo Clinic | 2 |
| McKesson Ventures | 2 |
| MemorialCare | 2 |
| Novartis | 2 |
| Philips | 2 |
| ResMed | 2 |
| Sante Ventures | 2 |
| Stanford Health Care | 2 |
| Threshold Ventures | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 5 | 21% |
| Participating | 19 | 79% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 60% |
| Co-led | 2 | 40% |
Team
Chief Experience Officer
Manager, Systems and Analytics
Medical Director of the Department of Refractive Surgery
Executive Director, Marketing Account Services
Chairman of Regional Oncology
Head, Section of Bronchology
Senior Dermatologist and Director Dermatopathology